论文部分内容阅读
目的分析丹红注射液与脑心通联合用药用于心脑血管疾病的治疗的临床效果,探讨心脑血管疾病的适宜治疗方法。方法回顾分析在2008年5月-2013年12月间收治的心脑血管疾病的患者150例,其中使用丹红注射液进行治疗的患者52例作为丹红组;脑心通治疗的患者50例作为脑心通组;联合使用丹红注射液和脑心通治疗的患者48例作为复合组。观察并比较3组患者治疗后症状等的改善情况以及有效率。结果 3组患者的临床症状改善明显,对心电图ST段、经颅多谱勒脑血流增快、减慢均有明显的改善,而复合组的改善最显著。丹红组和复合组患者的总有效率分别为94.23%、92.00%,而复合组为97.92%,显著高于前2组,差异有统计学意义(P<0.05)。结论丹红注射液联用脑心通对心脑血管疾病的疗效较好,能显著改善患者的症状等。
Objective To analyze the clinical effect of Danhong injection combined with Naoxintong in the treatment of cardio-cerebrovascular diseases and explore the appropriate treatment of cardiovascular and cerebrovascular diseases. Methods A retrospective analysis of 150 patients with cardiovascular and cerebrovascular diseases admitted between May 2008 and December 2013, of which 52 patients treated with Danhong injection as Danhong group; 50 patients treated with Naoxintong As brain Naoxintong group; combination of Danhong injection and Naoxintong treatment of 48 patients as a composite group. Observe and compare three groups of patients after treatment, such as the improvement of symptoms and efficiency. Results The clinical symptoms of the three groups improved obviously. The ST segment of the electrocardiogram, transcranial Doppler cerebral blood flow increased and slowed down significantly, while the improvement of the composite group was the most significant. The total effective rates of Danhong group and compound group were 94.23% and 92.00%, respectively, while those in compound group were 97.92%, which were significantly higher than those in the former two groups (P <0.05). Conclusion Danhong injection combined with Naoxintong is effective in treating cardiovascular and cerebrovascular diseases and can significantly improve the symptoms of patients.